Regulatory Paralysis by Preemption: GMO Food Labeling and Potentially More
Originally published on Environmental Law Prof Blog by CPR Member Scholar Lesley McAllister.
Did you know that as of July 2016, we have a new federal law mandating that genetically engineered food be labeled? It is true – see 7 U.S.C. § 1639(b)(2)(D) (Jul. 29, 2016). So when, you might ask, will you be able to know which of all those foods we buy at the grocery store are produced with GMOs?
It could be a very long wait. For one thing, the law – the National Bioengineered Food Disclosure Standard – didn't actually mandate a label that directly states that the food is a GE food. Rather, Congress left open the possibility that USDA allow scannable QR codes instead of on-package labeling as the means of disclosure. Congress charged the USDA with completing a study within one year (i.e. by July 2017) regarding whether QR codes would preclude consumer access to the disclosure (and if so, the agency shall provide "additional and comparable options to access the bioengineering disclosure.") As of early January, USDA didn't have the funds to conduct the study.
The Disclosure Standard itself is supposed to be established within two years of the passage of the law. But in Trump's administration, with its strong anti-regulatory ideology, the best guess is that forward motion will be further delayed. On the campaign trail in Iowa, Trump said he opposed efforts to require
In Williamson v. Mazda, SCOTUS Has Chance to Right Preemption Wrongs
by Bill Funk | November 01, 2010
Cross-posted from ACSblog. The Supreme Court will hear arguments on November 3 in a potentially important preemption case, Williamson v. Mazda Motor of America. In Williamson, a child was fatally injured in a collision when she was sitting in the center rear seat of a Mazda van, secured by a lap belt. The two other passengers in the vehicle, both wearing lap-shoulder belts, survived with minor injuries. The young Williamson, however, suffered severe abdominal injuries and internal bleeding because her
Group of AGs Urge Kerry-Graham-Lieberman to Not Preempt State Authorities on Climate
Seven state attorneys general have written a letter this week, released today, urging senators Kerry, Graham, and Lieberman to retain key state authorities on combating climate change in their upcoming bill (The Hill, National Journal). The letter, from the AGs of California, Delaware, Maine, Maryland, Massachusetts, Rhode Island and Vermont, follows two recent letters (see ClimateWire, subs. required) from 14 senators and from 14 state environmental protection agencies that called for some similar steps. (Update: And here's an April 7
Climate Legislation Federalism Choices: Reflections After Murkowski, Brown and in Anticipation of the Forthcoming Kerry-Graham-Lieberman Bill
Federalism battles over state roles under federal climate legislation may have appeared settled, but they are once again under debate. The previous leading bills–the Waxman-Markey bill passed by the House, and the Boxer-Kerry bill passed out of a committee in the Senate–lost momentum several months ago. After several months of legislative inaction, Senators Kerry, Graham, and Lieberman have been working on a new piece of climate legislation. After the senators’ comments indicated that this bill might broadly undercut state and
Why You Can't Get Your Day in Court After a Train Disaster and What the Federal Railroad Administration Needs to Do About It
Cross-posted from ACSblog. The citizens of Minot, North Dakota suffered a grave injustice on January 18, 2002 when a train derailment bathed much of that small town in a toxic cloud of poisonous gas that killed one person and injured almost 1,500 others. A detailed investigation by the National Transportation Safety Board concluded that the derailment was most likely caused by fractures in temporary joints that the railroad had installed to repair the track. When the victims sued the railroad
Schwarzenegger, in Copenhagen, Gives an Important Reminder of the Role of Subnational Governments. Like, the U.S. States, For Example.
by Ben Somberg | December 16, 2009
In his speech in Copenhagen Tuesday, California Governor Arnold Schwarzenegger applauded international leadership on climate change, but said that national or international agreements alone will not address the issue. He said that the "scientists, the capitalists and the activists" across the world have and will play an important role. And he talked about the job for subnational governments, like his own: While national governments have been fighting over emission targets, subnational governments have been adopting their own targets and laws
States Go to Bat for Improving Climate Change Legislation
Five State Attorneys General sent a letter to the Senate leadership on August 31st urging the Senate to enact strong climate legislation. The AGs letter is unusual in that states directly lobbying Congress on the details of federal legislation is a fairly infrequent phenomenon in and of itself. The AGs from California, Arizona, Connecticut, Delaware, and New Jersey are asking Congress to strengthen the House-passed American Clean Energy and Security Act (ACES), despite several important ways in which ACES would
Thoughts on Tuesday’s Senate Hearing on Preemption
Following up on Ben’s post about Tuesday’s Senate HELP Committee hearing on medical device preemption, I’d like to respond to three issues that came up during the question-and-answer session. Innovation: Senators Harkin and Hatch had a bit of a disagreement about whether the possibility of tort liability stifles innovation by medical device firms. Peter Barton Hutt, who Senator Hatch lauded as the “dean of all FDA lawyers,” noted that he sits on the board of ten small biotech firms and
McGarity Testifies on Medical Device Safety
CPR Member Scholar Thomas McGarity testified this afternoon at a hearing of the Senate Committee on Health, Education, Labor, and Pensions on the issue of medical device safety (written testimony, press release). Currently, individuals injured by a faulty medical device generally cannot sue the device manufacturer in state courts if that device was fully approved by the FDA, even if the manufacturer was aware of new research showing faults in the product. The Senate is considering a bill that would